My Cart [ 0 ]
New Products
New Services
News
Promotions
Home > Search Results
    32 products and services containing "vegf165"
    Please click vegf165 to try advanced search.
  • BP005736: Biotinylated Human VEGF R1/FLT-1 Protein with the C-His-Avi Tag

    Source: The recombinant Biotinylated Human VEGF R1/FLT-1 Protein, (amino acids Ser27-Asn756) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
    Activity: Immobilized recombinant Human VEGF165 protein with the C-His-Avi tag at 1 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Biotinylated Human VEGFR1 protein with the C-His tag with the EC50 of 46.4 ng/ml determined by ELISA (QC Test).
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

  • BP003701: Biotinylated Human VEGF R2/KDR Protein with the C-mFc Tag

    Source: The recombinant Biotinylated Human VEGF R2/KDR Protein, (amino acids Ala20-Glu764) fused with a mFc tag at the C-terminus, was produced in HEK 293 cells.
    Activity: Immobilized recombinant Human VEGF165 protein with the C-mFc tag at 5 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Biotinylated Human VEGF R2 protein with the C-mFc tag with the EC50 of 98.8 ng/ml determined by ELISA.
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

    BP004956: Biotinylated Human VEGF R2/KDR Protein with the C-His-Avi Tag

    Source: The recombinant Biotinylated Human VEGF R2/KDR Protein, (amino acids Ala20-Glu764) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
    Activity: Immobilized recombinant Biotinylated Human VEGF R2 protein with the C-His-Avi tag at 0.5 ug/ml (100 ul/well) on the streptavidin precoated plate (5 ug/ml). Dose response curve for the recombinant Anti-VEGF R2 Antibody protein with the C-hFc tag with the EC50 of 8.2 ng/ml determined by ELISA (QC Test).
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

  • BP005474: Biotinylated Human VEGF165 Protein with the C-His-Avi Tag

    Source: The recombinant Biotinylated Human VEGF165 Protein, (amino acids Ala27-Arg191) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
    Activity: Immobilized recombinant Anti-VEGF165 Antibody protein with the C-His-Avi tag at 1 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Biotinylated Human VEGF165 protein with the C-His tag with the EC50 of 11.6 ng/ml determined by ELISA.
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

  • C069P: Brolucizumab Biosimilar, VEGF-A Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The in vivo grade brolucizumab biosimilar specifically binds to the human vascular endothelial growth factor A (VEGF-A).
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by brolucizumab.

  • BP003162: FITC-Labeled Human VEGF165 Protein with the C-His-Avi Tag

    Source: The recombinant FITC-Labeled Human VEGF165 Protein, (amino acids Ala27-Arg191) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
    Activity: Immobilized recombinant FITC-Labeled Human VEGF165 protein with the C-His-Avi tag at 0.2 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Anti-VEGF165 Antibody protein with the C-hFc tag with the EC50 of 22.3 ng/ml determined by ELISA.
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

  • BP000991-PKA-241: Recombinant Human VEGFR1 D17

    Source: Insect Cells-derived.
    The activity of FLT1/Fc was determined by its ability to inhibit the VEGF-dependent proliferation of human umbilical vein endothelial cells. The ED50 for this effect is typically 10-30 ng/ml, corresponding to a specific activity of 33,333.33-100,000 units/mg.
    Purity > 95%, by SDS-PAGE.

  • BP003891: Human Neuropilin-1 Protein with the C-His Tag

    Source: The recombinant Human Neuropilin-1 Protein, (amino acids Phe22-Lys644) fused with a His tag at the C-terminus, was produced in HEK 293 cells.
    Activity: Immobilized recombinant Human VEGF165 protein with the C-His tag at 5 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Human Neuropilin-1 protein with the C-His tag with the EC50 of 0.57 ug/ml determined by ELISA.
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

  • BP004431: Human Neuropilin-2 Protein with the C-His Tag

    Source: The recombinant Human Neuropilin-2 Protein, (amino acids Gln23-Pro859) fused with a His tag at the C-terminus, was produced in HEK 293 cells.
    Activity:
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

  • BP005766: Human VEGF R2/KDR Protein with the C-mFc Tag

    Source: The recombinant Human VEGF R2/KDR Protein, (amino acids Ala20-Glu764) fused with a mFc tag at the C-terminus, was produced in HEK 293 cells.
    Activity: Immobilized recombinant Human VEGF165 protein with the C-mFc tag 1 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Human VEGF R2 protein with the C-mFc tag with the EC50 of 42.3 ng/ml determined by ELISA.
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

    BP005397: Human VEGF R2/KDR Protein with the C-His-Avi Tag

    Source: The recombinant Human VEGF R2/KDR Protein, (amino acids Ala20-Glu764) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
    Activity: Immobilized recombinant Human VEGF R2 protein with the C-His-Avi tag at 0.5 ug/ml (100 ul/Well). Dose response curve for the recombinant Anti-VEGFR2 Antibody protein with the C-hFc tag with the EC50 of 5.5 ng/ml determined by ELISA.
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

  • BP005778: Human VEGF165 Protein with No Tag

    Source: The recombinant Human VEGF165 Protein, (amino acids Ala27-Arg191) fused with No Tag, was produced in HEK 293 cells.
    Activity: Immobilized recombinant Human VEGF165 at 1 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Human VEGFR2, mFc tag with the EC50 of 42.3 ng/ml determined by ELISA.
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

    BP005436: Human VEGF165 Protein with the C-His-Avi Tag

    Source: The recombinant Human VEGF165 Protein, (amino acids Ala27-Arg191) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
    Activity: Immobilized recombinant Human VEGF165 protein with the C-His-Avi tag at 0.5 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Anti-VEGF165 Antibody protein with the C-hFc tag with the EC50 of 4.1 ng/ml determined by ELISA.
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

See our Privacy Policy